Savara Obtains Global Rights to Develop and Commercialize Apulmiq

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. NVDA
2. PSKY
3. META
4. LGND
5. SPY
6. MONC:IM
7. PTON
8. NYXH
9. LXEO
10. MONRY

Go back to Savara Obtains Global Rights to Develop and Commercialize Apulmiq
(NASDAQ: SVRA) Delayed: 5.48 +0.03 (0.55%)
Previous Close $5.45    52 Week High $ 
Open $5.52    52 Week Low $ 
Day High $5.53    P/E N/A 
Day Low $5.40    EPS $ 
Volume 115,108